Chip Wars Keep Churning
This article was originally published in Start Up
Executive SummaryThe war between Affymetrix and Oxford Gene Technology is far from over. But one more skirmish came to a close in early November, when a US federal court jury determined that Affymetrix had infringed an OGT patent covering the manufacture of gene chips. This was but one of many legal battles the two firms will fight in coming years, on European soil and in the US.
You may also be interested in...
Outsourcing is not just for mundane pharma services anymore. Increasingly, drugmakers are contracting for specialized R&D assistance they expect to provide strategic as well as tactical advantages.
Like other companies investigating entirely new ways of treating bacterial infections, biotech start-up Spero is increasingly aware that novel antibiotics may need to travel new clinical and regulatory pathways to market.
RxMP Therapeutics LLC is working to resolve excessive diffuse bleeding that is often associated with trauma, and also with certain orthopedic and cardiovascular surgeries. The start-up believes it can successfully treat excessive diffuse bleeding with particles produced from the membranes of red blood cells that have been freeze-dried and then, literally, blown to bits.